The influence of surgical-chemotheraphy interval on the clinical outcome of patients with ovarian carcinoma: The short-term morbidity and CA 125 level

The influence of surgical-chemotheraphy interval on the clinical outcome of patients with ovarian carcinoma: The short-term morbidity and CA 125 level

Bibliographic Details
Main Authors:	Shafiee, MN, Azmaniza, B, Maiza, T, Hatta, MD
Format:	Article
Language:	English
Published:	Penerbit UKM 2011
Online Access:	http://journalarticle.ukm.my/2846/1/198.pdf

Similar Items

Metal complexes in cancer chemotheraphy /
by: Keppler, Bernhard K.
Published: (1993)

Prevalence of K-RAS mutations and CA125 tumor marker in patients with ovarian carcinoma
by: Nazanin Bagherlou, et al.
Published: (2020-01-01)

Antibiotic and chemotheraphy : anti-infective agents and their use in therapy /
by: O'Grady, Francis
Published: (1997)

An Assessment of the Comfort Level of Cancer Patients with Receiving Chemotheraphy
by: Aysun CAN, et al.
Published: (2021-07-01)

CA125 and Ovarian Cancer: A Comprehensive Review
by: Parsa Charkhchi, et al.
Published: (2020-12-01)

CA-125 and Ceruloplasmin Levels in Ovarian Cancer Patients
by: Mangala Hegde, et al.
Published: (2015-09-01)

Are ROMA and HE4 more accurate than CA-125, in predicting of ovarian epithelial carcinoma?
by: Fariba Behnamfar, et al.
Published: (2023-01-01)

Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125
by: Szu-Ting Yang, et al.
Published: (2023-11-01)

Self-concept of cervical cancer patients after chemotheraphy in Yogyakarta
by: Nur Azizah Indriastuti, et al.
Published: (2021-05-01)

Increased CA125 Level in Ovarian Fibroma: Case Report
by: Sedigheh Ghasemian Dizajmehr, et al.
Published: (2020-04-01)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
by: Peter Hoffmann, et al.
Published: (2012-08-01)

Quality of life among lymphoma patients receiving chemotheraphy in Hospital USM
by: Fazilan, Nurul Sarah
Published: (2020)

Ibrutinib Could Suppress CA-125 in Ovarian Cancer: A Hypothesis
by: Julian Matthias Metzler, et al.
Published: (2020-12-01)

Ligand-based adoptive T cell targeting CA125 in ovarian cancer
by: Haihong Zhao, et al.
Published: (2023-09-01)

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
by: Xiayu Jin, et al.
Published: (2022-12-01)

Comparing the Diagnostic Value of the Risk of Ovarian Malignancy Algorithm and CA125 in Patients with Ovarian Mass
by: Alireza Rezaee, et al.
Published: (2019-07-01)

EMA/CO Combination Chemotheraphy in Gestational Trophoblastic Neoplasia: Update of Our Results
by: Tolga Taşçı, et al.
Published: (2016-02-01)

Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4
by: Aruni Ghose, et al.
Published: (2024-02-01)

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative
by: Charles J. Dunton, et al.
Published: (2021-08-01)

Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
by: Chloe E. Barr, et al.
Published: (2023-02-01)

Correlation of Sonographic Morphologic Index and CA-125 in predicting the Nature of Ovarian Tumor
by: Poonam Gusain, et al.
Published: (2019-11-01)

Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer
by: Jie-Ping Chen, et al.
Published: (2019-07-01)

HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
by: Michel Fabbro, et al.
Published: (2024-01-01)

Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer.
by: Fahmy T Ali, et al.
Published: (2022-01-01)

Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
by: Fahmy T. Ali, et al.
Published: (2022-01-01)

The Role of Salivary and Serum Ca125 and Routine Blood Tests in Patients with Ovarian Malignancies
by: Ante Vuković, et al.
Published: (2021-01-01)

Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
by: Gupta Digant, et al.
Published: (2009-10-01)

Meigs’ Syndromes with Extremelly High CA125 Level Mimicking Advanced Ovarian Cancer
by: Özgür Koçak, et al.
Published: (2016-04-01)

Tubo-ovarian mass with raised CA-125 in a 21-year-old female
by: Roli Purwar, et al.
Published: (2022-06-01)

ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage
by: Andrew N. Stephens, et al.
Published: (2024-03-01)

Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
by: Shafiee MN,, et al.
Published: (2013)

Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels
by: Fei Wang, et al.
Published: (2018-11-01)

RELATION BETWEEN REGULATORY T CELLS, CA-125 LEVEL AND TUMOR MASS IN OVARIAN CANCER PATIENTS
by: E. R. Chernykh, et al.
Published: (2014-07-01)

Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
by: Er Yue, et al.
Published: (2021-08-01)

Role of serum VEGF-A biomarker for early diagnosis of ovarian cancer instead of CA-125
by: Nafeesa Maryam, et al.
Published: (2021-07-01)

Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
by: Gupta Digant, et al.
Published: (2010-10-01)

Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125
by: Fraser, Christopher C, et al.
Published: (2023)

Preoperative Differentiation Between Malignant and Benign Ovarian Masses in Patients with Normal CA-125 Levels
by: Ebru Ersoy, et al.
Published: (2016-08-01)

Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer
by: Zhuowei Gu, et al.
Published: (2018-05-01)

Evaluating Specivity, Sensitivity, Positive and Negative Predictive Values of CA125 for Diagnosing Ovarian Cancer
by: Elahe Fini, et al.
Published: (2021-08-01)